Accessibility: Skip TopNav
Thomas Equels, CEO of Hemispherx Biopharma
Thomas K. Equels is the CEO of Hemispherx Biopharma
Format
JPEG
Source
AIM ImmunoTech Inc.
Downloads
Original
Large
Medium
Small